CytometryVolume 34, Issue 4 p. 203-204 PerspectiveFree Access Quantitative fluorescence: To count or not to count. Is that the question? Janet K. A. Nicholson, Corresponding Author Janet K. A. Nicholson [email protected] Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia1–1202 (A25), 1600 Clifton Rd., N.E., Atlanta, GA 30333Search for more papers by this authorMaryalice Stetler-Stevenson, Maryalice Stetler-Stevenson Flow Cytometry Unit, Department of Pathology, Division of Clinical Sciences, National Cancer Institute, Bethesda, MarylandSearch for more papers by this author Janet K. A. Nicholson, Corresponding Author Janet K. A. Nicholson [email protected] Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia1–1202 (A25), 1600 Clifton Rd., N.E., Atlanta, GA 30333Search for more papers by this authorMaryalice Stetler-Stevenson, Maryalice Stetler-Stevenson Flow Cytometry Unit, Department of Pathology, Division of Clinical Sciences, National Cancer Institute, Bethesda, MarylandSearch for more papers by this author First published: 26 December 2002 https://doi.org/10.1002/(SICI)1097-0320(19980815)34:4<203::AID-CYTO5>3.0.CO;2-GCitations: 2AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. Literature Cited 1 Borowitz MJ, Bray R, Gascoyne R, Melnick S, Parker JW, Picker L, Stetler-Stevenson M: U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Data analysis and interpretation Cytometry 30: 236– 244, 1997. 2 Kuchnio M, Sausville EA, Jaffe ES, Greiner T, Foss FM, McClanahan J, Fukushima P, Stetler-Stevenson M: Flow cytometric detection of neoplastic T cells in patients with mycosis fungoides based upon levels of T-cell receptor expression. Am J Clin Pathol 102: 856– 860, 1994. 3 Stelzer GT, Marti G, Hurley A, McCoy P, Lovett EJ, Schwartz A: U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Standardization and validation of laboratory procedures Cytometry 30: 214– 230, 1997. 4 Lui Z, Cumberland WG, Hultin LE, Prince HE, Detels R, Giorgi JV: Elevated CD38 antigen expression on CD81 T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD41 cell count, soluble antigen activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol 16: 83– 92, 1997. 5 Hultin L, Matud JL, Giorgi JV: Quantitation of CD38 activation antigen expression on CD81 T cells in HIV-1 infection using CD4 expression on CD41 T lymphocytes as a biological calibrator. Cytometry 1998, in press. 6 Davis KA, Abrams B, Iyer S, Hoffman RA, Bishop JE: Determination of CD4 antigen density on cells: Role of antibody valency, avidity, clone, and conjugation. Cytometry 1998, in press. Citing Literature Volume34, Issue415 August 1998Pages 203-204 ReferencesRelatedInformation